Clinical significance of kallikrein 5 as a novel prognostic biomarker in gastric adenocarcinoma

by Abuduhadeer, X., Aihesan, K., Xu, X., Yilihamu, M., Zhang, W., Zhao, Y.
Published 2021

Case report: Human pentastomiasis caused by Armillifer moniliformis in Malaysian Borneo

by Heo, C.C, Latif, B., Omar, E., Othman, N., Tappe, D.

The clinical significance of vitamin D levels and vitamin D receptor mRNA expression in colorectal neoplasms

by Ding, X., Fang, Y., Huang, J., Song, H., Zhou, J.
Published 2021

Abnormal TP53 Predicts Risk of Progression in Patients With Barrett's Esophagus Regardless of a Diagnosis of Dysplasia

by Akarca, F.G, Bass, A.J, Kim, A., Lash, R., Noffsinger, A., Nowden, L., Rara, M., Redston, M., Stachler, M.D, Stapleton, D.
Published 2022

Long noncoding RNA TUG1 upregulates VEGFA to enhance malignant behaviors in stomach adenocarcinoma by sponging miR-29c-3p

by Cao, J., Cheng, H., Hu, X., Jin, Y.
Published 2021

Cluster analysis evaluating PM2.5, occupation risk and mode of transportation as surrogates for air-pollution and the impact on lung cancer diagnosis and 1-year mortality

by Hamid, F.A, Hassan, A., Hassan, T., Jeyabalan, T., Latif, M.T, Soo, C.I, Vadiveel, Y., Wahab, S.A, Yu-lin, A.B
Published 2019

The impact of routine histopathological examination on cholecystectomy specimens from an Asian demographic

by Chin, K.F, Khoo, Y.Y, Krishnasamy, T., Mohammad, A.A

A phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prosta...

by Agarwal, N., Azad, A., Benzaghou, F., Carles, J., Chowdhury, S., Kerloeguen, Y., Kimura, A., Mcgregor, B., Merseburger, A.S, Mohamed, N., Oudard, S., Pal, S., Panneerselvam, A., Saad, F., Soares, A., Wang, F.
Published 2022

NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantita...

by Han, Q., Huang, W., Jiang, Z., Liu, L., Liu, S., Qin, J., Xiao, Y., Xie, J.
Published 2021

N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment

by Guo, M., Li, Z., Ming, L., Qin, Z., Wan, J., Wang, Y., Yang, Z., Zhao, Z., Zheng, J.
Published 2021

Guanylate-binding protein 1 correlates with advanced tumor features, and serves as a prognostic biomarker for worse survival in lung adenocarcinoma patients

by Gao, F., Li, L., Qu, J., Wan, Q.
Published 2021

Aberrant expression of HIF3A in plasma of patients with non-small cell lung cancer and its clinical significance

by Chen, Y., Gong, P., Wei, L., Yuan, N.
Published 2021

Dysregulated ferroptosis-related genes indicate potential clinical benefits for anti–PD-1/PD-L1 immunotherapy in lung adenocarcinoma

by Chen, Y., Li, T., Zhang, X., Zhou, M.
Published 2021

Identification of prostate cancer specific methylation biomarkers from a multi-cancer analysis

by Li, C., Pu, Y., Wang, X., Yuan, H.
Published 2021

Combined fibrinogen-to-pre-albumin ratio and carbohydrate antigen 19–9 score is a promising metric to predict progression of metastatic colorectal mucinous adenocarcinoma

by Cheng, X.-X, Fu, M., Liao, Y.-C, Wang, X.-F
Published 2021

Development of risk prediction models for lung cancer based on tumor markers and radiological signs

by Bi, X., Chen, T., Lu, Y., Tu, Y., Wu, Y.
Published 2021

miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia—archival samples study

by Garbicz, F., Gondek, A., Grzywa, T.M, Klicka, K., Marczewska, J.M, Paskal, W., Pełka, K., Szczepaniak, K., Włodarski, P.K
Published 2021

Autologous dermis-fat grafts in head and neck patients: Indications and evaluation in reconstructive surgery

by Baum, S.H, Mohr, C.
Published 2018

Long non-coding RNA MALAT1 and its target microRNA-125b associate with disease risk, severity, and major adverse cardiovascular event of coronary heart disease

by Feng, Q., Liu, L., Lv, F., Yang, X.
Published 2021

Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer

by Bachier, C., Bai, J., Batrakou, D., Blumenschein, G.R, Broad, R., Devarakonda, S., Doger de Spéville, B., Edelman, M.J, Fayngerts, S., Fracasso, P.M, Frigault, M.J, Gainor, J., Gerry, A., Govindan, R., Heymach, J.V, Holdich, T., Hyland, N., Johnson, M., Lam, V.K, Marks, D., Moreno, V., Navenot, J.-M, Norry, E., Olszanski, A.J, Pentony, M.M, Sanderson, J.P, Wolchinsky, Z.
Published 2022